Aclaris Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 29.4% | -1,343.2% | -1,360.3% |
| FY2022 | 46.5% | -1,195.5% | -1,156.3% |
| FY2023 | 87.3% | -360.0% | -327.2% |
| FY2024 | 85.1% | -758.2% | -705.5% |
| FY2025 | 73.3% | -975.9% | -829.6% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 29.4% | -1,343.2% | -1,360.3% |
| FY2022 | 46.5% | -1,195.5% | -1,156.3% |
| FY2023 | 87.3% | -360.0% | -327.2% |
| FY2024 | 85.1% | -758.2% | -705.5% |
| FY2025 | 73.3% | -975.9% | -829.6% |